Acitretin-induced alopecia areata: a case report.

Abstract

Alopecia areata is a common form of non-scarring hair disorder. The development of alopecia areata during anti-psoriatic treatment has been reported with the systemic therapies such as infliximab, etanercept, adalimumab, alefacept and efalizumab. Retinoid-induced alopecia areata on the eyelash and eyebrow has not been reported in the literature. We report a female patient who presented with alopecia areata of the eyebrow and eyelash one month after the initiation of acitretin therapy for psoriasis.

• Authors: Emin Ozlu, Ayse Serap Karadag, Necmettin Akdeniz, Tugba Kevser Uzuncakmak
• Journal: Cutaneous and ocular toxicology (Cutan Ocul Toxicol) Vol. 34 Issue 3 Pg. 248-50 ( 2015) ISSN: 1556-9535 [Electronic] England
• PMID: 25198403 (Publication Type: Case Reports, Journal Article)

Chemical References

• Keratolytic Agents
• Acitretin

Topics

• Acitretin (adverse effects, therapeutic use)
• Adult
• Alopecia Areata (chemically induced)
• Female
• Humans
• Keratolytic Agents (adverse effects, therapeutic use)
• Psoriasis (drug therapy)